2022 Nelson's Pediatric Antimicrobial Therapy, 28th Edition

Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.

For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

TOPICS INCLUDE

• Antimicrobial Therapy by Clinical Syndromes
• Antimicrobial Therapy for Neonates
• Choosing Among[list]
• Antibiotics
• Antifungal Agents
• Antiviral Agents
• Antiparasitic Agents

New in the 28th Edition

• Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
• Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
• Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
• Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
• New dosing for posaconazole suspension formulation
• New approaches to mucormycosis
• Added baloxavir for children 12+ years old
• Online updates of COVID-19 therapies once emergency use authorization in children athttp://www.aap.org/nelsonslist * Updated Nelson’s app also available